Bank of America’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of America’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,000	Closed	-$1.17M	–	8161
2024 Q2	$1.17M	Hold	50,000	–	–	﹤0.01%	4807
2024 Q1	$1.44M	Hold	50,000	–	–	﹤0.01%	4679
2023 Q4	$1.64M	Hold	50,000	–	–	﹤0.01%	4582
2023 Q3	$1.39M	Hold	50,000	–	–	﹤0.01%	4566
2023 Q2	$1.7M	Sell	50,000 -40,000	-44%	-$1.26M	﹤0.01%	4350
2023 Q1	$2.71M	Buy	90,000 +7,100	+9%	+$220K	﹤0.01%	4090
2022 Q4	$2.34M	Buy	+82,900	New	+$2.63M	﹤0.01%	4104
2022 Q3	–	Sell	-5,100	Closed	-$161K	–	7810
2022 Q2	$161K	Sell	5,100 -494,900	-99%	-$17.3M	﹤0.01%	6233
2022 Q1	$23M	Buy	500,000 +100,000	+25%	+$4.77M	﹤0.01%	2017
2021 Q4	$24.5M	Sell	400,000 -290,000	-42%	-$20M	﹤0.01%	2026
2021 Q3	$51.6M	Buy	690,000 +650,000	+1,625%	+$54.5M	0.01%	1333
2021 Q2	$3.7M	Sell	40,000 -948,800	-96%	-$80.7M	﹤0.01%	3793
2021 Q1	$87.7M	Buy	+988,800	New	+$98.1M	0.01%	957

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Bank of America's ARKG Position: Q1 2026 in Review

Bank of America reduced its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, selling an estimated $14.1M and leaving 873,702 shares worth $23.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2268.

Bank of America first reported a position in ARKG in Q1 2018 and has held it in 33 quarters since. The position peaked at $234M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Bank of America held 873,702 shares of ARK Genomic Revolution ETF worth $23.1M as of Q1 2026.
Bank of America sold 480,026 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.1M.
ARK Genomic Revolution ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2268 holding.
Bank of America first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 33 quarters since.
Bank of America's ARK Genomic Revolution ETF position peaked at $234M in Q2 2021.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.